A Prospective Randomized Controlled Clinical Trial to evaluate the Efficacy and Safety of Ayurveda Interventions (Ashwagandha Tablet and Shunti Capsule) in the management of COVID-19 infection (Mild to Moderate symptoms)

Central Council for Research in Ayurvedic Sciences New Delhi0 sites48 target enrollmentTBD

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor: Central Council for Research in Ayurvedic Sciences New Delhi
Enrollment: 48
Status: Completed
Last Updated: 4 years ago

No summary available.

Registry

who.int

Start Date

TBD

End Date

February 21, 2021

Last Updated

4 years ago

Study Type

Interventional

Sponsor

Central Council for Research in Ayurvedic Sciences New Delhi

•1\. Mild to moderate cases registered in the Hospital, with COVID 2019 (Confirmed by Antigen test/ RT\-PCR) quarantined at identified hospital set up.
•2\. Participants who can take medicines orally
•3\. Patients with either sex, 18 to 75 years age
•4\. Patients willing to provide signed informed consent

•1\. Cases of severe vomiting which would make oral administration of medicine difficult.
•2\. Patients with hyperacidity and gastric ulcer to be excluded.
•3\. Chronic, Severe, Unstable, Uncontrolled co\-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study
•4\. Cases of respiratory failure and requiring mechanical ventilation.
•5\. Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
•6\. Pregnant or lactating women
•7\. Any patient with proved sensitivity to the trial drugs may be excluded.
•8\. Any other condition, which as per the investigator would jeopardize the outcome of the trial.